カテゴリー： 世界, 医療/バイオ, QYResearch

口腔内崩壊溶解フィルムのグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム

【英語タイトル】Global Oral Disintegrating and Dissolving Film Market Research Report 2023

QYResearchが出版した調査資料（QYR23MA8209）・商品コード：QYR23MA8209
・発行会社（調査会社）：QYResearch
・発行日：2023年3月（※2025年版があります。お問い合わせください。）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

本調査レポートは世界の口腔内崩壊溶解フィルム市場について調査・分析し、世界の口腔内崩壊溶解フィルム市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（口腔分散性フィルム、口腔粘膜フィルム）、用途別セグメント分析（病院/クリニック、ドラッグストア、Eコマース）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Aquestive Therapeutics、Kyukyu Pharmaceutical、BioDelivery(BDSI)、IntelGenx、Tapemark、Shilpa Therapeutics、CL Pharm、Lubrizol Life Science、Adhex Pharma、DK Livkon、Arx Pharma、Aavishkar、ZIM Laboratories、Umang Pharmaceuticals、Cure Pharmaceuticalなどが含まれています。世界の口腔内崩壊溶解フィルム市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、口腔内崩壊溶解フィルム市場規模を推定する際に考慮しました。

・口腔内崩壊溶解フィルム市場の概要
- 製品の定義
- 口腔内崩壊溶解フィルムのタイプ別セグメント
- 世界の口腔内崩壊溶解フィルム市場規模：タイプ別分析（口腔分散性フィルム、口腔粘膜フィルム）
- 口腔内崩壊溶解フィルムの用途別セグメント
- 世界の口腔内崩壊溶解フィルム市場規模：用途別分析（病院/クリニック、ドラッグストア、Eコマース）
- 世界の口腔内崩壊溶解フィルム市場規模予測（2018年-2029年）
- 口腔内崩壊溶解フィルムの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 口腔内崩壊溶解フィルム市場の競争状況およびトレンド

・口腔内崩壊溶解フィルムの地域別市場規模
- 北米の口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- アメリカの口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- ヨーロッパの口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- アジア太平洋の口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- 中国の口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- 日本の口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- 韓国の口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- インドの口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- オーストラリアの口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- 中南米の口腔内崩壊溶解フィルム市場規模（2018年-2029年）
- 中東・アフリカの口腔内崩壊溶解フィルム市場規模（2018年-2029年）

・タイプ別セグメント：口腔分散性フィルム、口腔粘膜フィルム
- 世界の口腔内崩壊溶解フィルムのタイプ別販売量（2018年-2023年）
- 世界の口腔内崩壊溶解フィルムのタイプ別売上（2018年-2023年）
- 世界の口腔内崩壊溶解フィルムのタイプ別価格

・用途別セグメント：病院/クリニック、ドラッグストア、Eコマース
- 世界の口腔内崩壊溶解フィルムの用途別販売量（2018年-2023年）
- 世界の口腔内崩壊溶解フィルムの用途別売上（2018年-2023年）
- 世界の口腔内崩壊溶解フィルムの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Aquestive Therapeutics、Kyukyu Pharmaceutical、BioDelivery(BDSI)、IntelGenx、Tapemark、Shilpa Therapeutics、CL Pharm、Lubrizol Life Science、Adhex Pharma、DK Livkon、Arx Pharma、Aavishkar、ZIM Laboratories、Umang Pharmaceuticals、Cure Pharmaceutical

・産業チェーンと販売チャネルの分析
- 口腔内崩壊溶解フィルム産業チェーン分析
- 口腔内崩壊溶解フィルムの主要原材料
- 口腔内崩壊溶解フィルムの販売チャネル
- 口腔内崩壊溶解フィルムのディストリビューター
- 口腔内崩壊溶解フィルムの主要顧客

・口腔内崩壊溶解フィルム市場ダイナミクス
- 口腔内崩壊溶解フィルムの業界動向
- 口腔内崩壊溶解フィルム市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

The films are designed to dissolve upon contact with a wet surface, such as the tongue, within a few seconds, meaning the consumer can take the product without need for additional liquid. 
Highlights
The global Oral Disintegrating and Dissolving Film market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oral Disintegrating and Dissolving Film is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oral Disintegrating and Dissolving Film is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Oral Disintegrating and Dissolving Film include Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI), IntelGenx, Tapemark, Shilpa Therapeutics, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Disintegrating and Dissolving Film, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Disintegrating and Dissolving Film.
The Oral Disintegrating and Dissolving Film market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oral Disintegrating and Dissolving Film market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Disintegrating and Dissolving Film manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Aquestive Therapeutics
Kyukyu Pharmaceutical
BioDelivery(BDSI)
IntelGenx
Tapemark
Shilpa Therapeutics
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical
Segment by Type
Orodispersible Film
Oromucosal Film
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Disintegrating and Dissolving Film manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Disintegrating and Dissolving Film in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Oral Disintegrating and Dissolving Film Market Overview
1.1 Product Overview and Scope of Oral Disintegrating and Dissolving Film
1.2 Oral Disintegrating and Dissolving Film Segment by Type
1.2.1 Global Oral Disintegrating and Dissolving Film Market Value Comparison by Type (2023-2029)
1.2.2 Orodispersible Film
1.2.3 Oromucosal Film
1.3 Oral Disintegrating and Dissolving Film Segment by Application
1.3.1 Global Oral Disintegrating and Dissolving Film Market Value by Application: (2023-2029)
1.3.2 Hospital and Clinic
1.3.3 Drug Store
1.3.4 E-commerce
1.4 Global Oral Disintegrating and Dissolving Film Market Size Estimates and Forecasts
1.4.1 Global Oral Disintegrating and Dissolving Film Revenue 2018-2029
1.4.2 Global Oral Disintegrating and Dissolving Film Sales 2018-2029
1.4.3 Global Oral Disintegrating and Dissolving Film Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Disintegrating and Dissolving Film Market Competition by Manufacturers
2.1 Global Oral Disintegrating and Dissolving Film Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Disintegrating and Dissolving Film Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Disintegrating and Dissolving Film Average Price by Manufacturers (2018-2023)
2.4 Global Oral Disintegrating and Dissolving Film Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Disintegrating and Dissolving Film, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Disintegrating and Dissolving Film, Product Type & Application
2.7 Oral Disintegrating and Dissolving Film Market Competitive Situation and Trends
2.7.1 Oral Disintegrating and Dissolving Film Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Disintegrating and Dissolving Film Players Market Share by Revenue
2.7.3 Global Oral Disintegrating and Dissolving Film Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Disintegrating and Dissolving Film Retrospective Market Scenario by Region
3.1 Global Oral Disintegrating and Dissolving Film Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Disintegrating and Dissolving Film Global Oral Disintegrating and Dissolving Film Sales by Region: 2018-2029
3.2.1 Global Oral Disintegrating and Dissolving Film Sales by Region: 2018-2023
3.2.2 Global Oral Disintegrating and Dissolving Film Sales by Region: 2024-2029
3.3 Global Oral Disintegrating and Dissolving Film Global Oral Disintegrating and Dissolving Film Revenue by Region: 2018-2029
3.3.1 Global Oral Disintegrating and Dissolving Film Revenue by Region: 2018-2023
3.3.2 Global Oral Disintegrating and Dissolving Film Revenue by Region: 2024-2029
3.4 North America Oral Disintegrating and Dissolving Film Market Facts & Figures by Country
3.4.1 North America Oral Disintegrating and Dissolving Film Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Disintegrating and Dissolving Film Sales by Country (2018-2029)
3.4.3 North America Oral Disintegrating and Dissolving Film Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Disintegrating and Dissolving Film Market Facts & Figures by Country
3.5.1 Europe Oral Disintegrating and Dissolving Film Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Disintegrating and Dissolving Film Sales by Country (2018-2029)
3.5.3 Europe Oral Disintegrating and Dissolving Film Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Disintegrating and Dissolving Film Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Disintegrating and Dissolving Film Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Disintegrating and Dissolving Film Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Disintegrating and Dissolving Film Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Disintegrating and Dissolving Film Market Facts & Figures by Country
3.7.1 Latin America Oral Disintegrating and Dissolving Film Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Disintegrating and Dissolving Film Sales by Country (2018-2029)
3.7.3 Latin America Oral Disintegrating and Dissolving Film Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Disintegrating and Dissolving Film Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Disintegrating and Dissolving Film Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Disintegrating and Dissolving Film Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Disintegrating and Dissolving Film Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Disintegrating and Dissolving Film Sales by Type (2018-2029)
4.1.1 Global Oral Disintegrating and Dissolving Film Sales by Type (2018-2023)
4.1.2 Global Oral Disintegrating and Dissolving Film Sales by Type (2024-2029)
4.1.3 Global Oral Disintegrating and Dissolving Film Sales Market Share by Type (2018-2029)
4.2 Global Oral Disintegrating and Dissolving Film Revenue by Type (2018-2029)
4.2.1 Global Oral Disintegrating and Dissolving Film Revenue by Type (2018-2023)
4.2.2 Global Oral Disintegrating and Dissolving Film Revenue by Type (2024-2029)
4.2.3 Global Oral Disintegrating and Dissolving Film Revenue Market Share by Type (2018-2029)
4.3 Global Oral Disintegrating and Dissolving Film Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Disintegrating and Dissolving Film Sales by Application (2018-2029)
5.1.1 Global Oral Disintegrating and Dissolving Film Sales by Application (2018-2023)
5.1.2 Global Oral Disintegrating and Dissolving Film Sales by Application (2024-2029)
5.1.3 Global Oral Disintegrating and Dissolving Film Sales Market Share by Application (2018-2029)
5.2 Global Oral Disintegrating and Dissolving Film Revenue by Application (2018-2029)
5.2.1 Global Oral Disintegrating and Dissolving Film Revenue by Application (2018-2023)
5.2.2 Global Oral Disintegrating and Dissolving Film Revenue by Application (2024-2029)
5.2.3 Global Oral Disintegrating and Dissolving Film Revenue Market Share by Application (2018-2029)
5.3 Global Oral Disintegrating and Dissolving Film Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aquestive Therapeutics
6.1.1 Aquestive Therapeutics Corporation Information
6.1.2 Aquestive Therapeutics Description and Business Overview
6.1.3 Aquestive Therapeutics Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aquestive Therapeutics Oral Disintegrating and Dissolving Film Product Portfolio
6.1.5 Aquestive Therapeutics Recent Developments/Updates
6.2 Kyukyu Pharmaceutical
6.2.1 Kyukyu Pharmaceutical Corporation Information
6.2.2 Kyukyu Pharmaceutical Description and Business Overview
6.2.3 Kyukyu Pharmaceutical Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kyukyu Pharmaceutical Oral Disintegrating and Dissolving Film Product Portfolio
6.2.5 Kyukyu Pharmaceutical Recent Developments/Updates
6.3 BioDelivery(BDSI)
6.3.1 BioDelivery(BDSI) Corporation Information
6.3.2 BioDelivery(BDSI) Description and Business Overview
6.3.3 BioDelivery(BDSI) Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BioDelivery(BDSI) Oral Disintegrating and Dissolving Film Product Portfolio
6.3.5 BioDelivery(BDSI) Recent Developments/Updates
6.4 IntelGenx
6.4.1 IntelGenx Corporation Information
6.4.2 IntelGenx Description and Business Overview
6.4.3 IntelGenx Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.4.4 IntelGenx Oral Disintegrating and Dissolving Film Product Portfolio
6.4.5 IntelGenx Recent Developments/Updates
6.5 Tapemark
6.5.1 Tapemark Corporation Information
6.5.2 Tapemark Description and Business Overview
6.5.3 Tapemark Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tapemark Oral Disintegrating and Dissolving Film Product Portfolio
6.5.5 Tapemark Recent Developments/Updates
6.6 Shilpa Therapeutics
6.6.1 Shilpa Therapeutics Corporation Information
6.6.2 Shilpa Therapeutics Description and Business Overview
6.6.3 Shilpa Therapeutics Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shilpa Therapeutics Oral Disintegrating and Dissolving Film Product Portfolio
6.6.5 Shilpa Therapeutics Recent Developments/Updates
6.7 CL Pharm
6.6.1 CL Pharm Corporation Information
6.6.2 CL Pharm Description and Business Overview
6.6.3 CL Pharm Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CL Pharm Oral Disintegrating and Dissolving Film Product Portfolio
6.7.5 CL Pharm Recent Developments/Updates
6.8 Lubrizol Life Science
6.8.1 Lubrizol Life Science Corporation Information
6.8.2 Lubrizol Life Science Description and Business Overview
6.8.3 Lubrizol Life Science Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Lubrizol Life Science Oral Disintegrating and Dissolving Film Product Portfolio
6.8.5 Lubrizol Life Science Recent Developments/Updates
6.9 Adhex Pharma
6.9.1 Adhex Pharma Corporation Information
6.9.2 Adhex Pharma Description and Business Overview
6.9.3 Adhex Pharma Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Adhex Pharma Oral Disintegrating and Dissolving Film Product Portfolio
6.9.5 Adhex Pharma Recent Developments/Updates
6.10 DK Livkon
6.10.1 DK Livkon Corporation Information
6.10.2 DK Livkon Description and Business Overview
6.10.3 DK Livkon Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.10.4 DK Livkon Oral Disintegrating and Dissolving Film Product Portfolio
6.10.5 DK Livkon Recent Developments/Updates
6.11 Arx Pharma
6.11.1 Arx Pharma Corporation Information
6.11.2 Arx Pharma Oral Disintegrating and Dissolving Film Description and Business Overview
6.11.3 Arx Pharma Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Arx Pharma Oral Disintegrating and Dissolving Film Product Portfolio
6.11.5 Arx Pharma Recent Developments/Updates
6.12 Aavishkar
6.12.1 Aavishkar Corporation Information
6.12.2 Aavishkar Oral Disintegrating and Dissolving Film Description and Business Overview
6.12.3 Aavishkar Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aavishkar Oral Disintegrating and Dissolving Film Product Portfolio
6.12.5 Aavishkar Recent Developments/Updates
6.13 ZIM Laboratories
6.13.1 ZIM Laboratories Corporation Information
6.13.2 ZIM Laboratories Oral Disintegrating and Dissolving Film Description and Business Overview
6.13.3 ZIM Laboratories Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ZIM Laboratories Oral Disintegrating and Dissolving Film Product Portfolio
6.13.5 ZIM Laboratories Recent Developments/Updates
6.14 Umang Pharmaceuticals
6.14.1 Umang Pharmaceuticals Corporation Information
6.14.2 Umang Pharmaceuticals Oral Disintegrating and Dissolving Film Description and Business Overview
6.14.3 Umang Pharmaceuticals Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Umang Pharmaceuticals Oral Disintegrating and Dissolving Film Product Portfolio
6.14.5 Umang Pharmaceuticals Recent Developments/Updates
6.15 Cure Pharmaceutical
6.15.1 Cure Pharmaceutical Corporation Information
6.15.2 Cure Pharmaceutical Oral Disintegrating and Dissolving Film Description and Business Overview
6.15.3 Cure Pharmaceutical Oral Disintegrating and Dissolving Film Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cure Pharmaceutical Oral Disintegrating and Dissolving Film Product Portfolio
6.15.5 Cure Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Disintegrating and Dissolving Film Industry Chain Analysis
7.2 Oral Disintegrating and Dissolving Film Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Disintegrating and Dissolving Film Production Mode & Process
7.4 Oral Disintegrating and Dissolving Film Sales and Marketing
7.4.1 Oral Disintegrating and Dissolving Film Sales Channels
7.4.2 Oral Disintegrating and Dissolving Film Distributors
7.5 Oral Disintegrating and Dissolving Film Customers
8 Oral Disintegrating and Dissolving Film Market Dynamics
8.1 Oral Disintegrating and Dissolving Film Industry Trends
8.2 Oral Disintegrating and Dissolving Film Market Drivers
8.3 Oral Disintegrating and Dissolving Film Market Challenges
8.4 Oral Disintegrating and Dissolving Film Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer


※参考情報

口腔内崩壊溶解フィルム（Oral Disintegrating and Dissolving Film）は、近年注目されている医療用製剤の一形態です。このフィルムは、口腔内で迅速に崩壊し溶解する特性を持ち、従来の錠剤やカプセルに代わって使用されることが多くなっています。以下に、口腔内崩壊溶解フィルムの概念、特徴、種類、用途、関連技術について詳しく説明します。

口腔内崩壊溶解フィルムの定義として、薄いフィルム状の製剤であり、口腔内で水分に触れることで速やかに崩壊し、成分が溶解することが特徴です。この特性により、従来の経口投与製剤とは異なり、飲み込む必要がないため、特に高齢者や嚥下障害を持つ患者にとって、大変便利かつ安全な代替手段となります。

このフィルムの特徴の一つは、その違和感の少なさです。通常の錠剤やカプセルに比べて、口の中での存在感が軽く、服用時に不快感を引き起こすことが少なくなっています。また、味や匂いを抑える技術が進化しているため、味覚的な抵抗感も低いことから、子供や高齢者でも使用しやすくなっています。

さらに、口腔内崩壊溶解フィルムは、製剤の設計によって成分の放出速度を調整できる優れた利点を持っています。これにより、急速に効果を発現させたい薬剤に最適な形態を提供でき、患者が薬の効果をより早く感じられるよう工夫されています。

種類については、大きく分けて2つのタイプがあります。一つは、崩壊型フィルムで、口腔内で水分と接触することで迅速に崩壊し、薬効成分を瞬時に放出します。もう一つは、溶解型フィルムで、こちらは時間をかけて成分を均等に溶解させ、持続的に効果を持たせることができます。この2種類は、患者のニーズや病状に応じて使い分けられます。

口腔内崩壊溶解フィルムの用途は広範囲にわたりますが、主に以下のような領域で使用されています。まず、精神的な症状を軽減するために使用される抗精神病薬や抗うつ薬です。これらの薬剤は、患者が服用を怠ったり、飲み込むことが難しい場合でも、容易に服用できる点で優れています。また、鎮痛剤や抗ヒスタミン剤など、急速に効果が求められる薬剤の投与にも適しています。さらに、抗生物質や抗ウイルス薬などの治療剤も、特に子供や高齢者の治療において使用されることが増えています。

関連技術としては、材料科学や製造技術の進歩があります。口腔内崩壊溶解フィルムの製造には、ポリマーやその他の成分が使用されますが、これらの材料は自然素材からの抽出物や合成物が含まれています。最近では、生分解性や非毒性の材料が使用されることも増えており、環境負荷への配慮もなされています。また、フィルムの成分に味付けを施す技術や、成分の安定性を保つためのコーティング技術も進化してきました。

今後の展望としては、口腔内崩壊溶解フィルムのさらに多様な用途が期待されています。慢性疾患や特定疾患の新たな治療法としての研究が進められており、個別化医療への適用も検討されています。さらに、デジタル技術との連携も進むことで、患者の服薬管理や効果のモニタリングが行いやすくなり、医療の質の向上が図られるでしょう。

以上のように、口腔内崩壊溶解フィルムは、医療における重要な製剤の一つとして位置づけられ、その利便性や有効性から今後ますます注目されることでしょう。患者の生活の質を向上させるために、大切な役割を果たしていくことが期待されます。


★調査レポート[口腔内崩壊溶解フィルムのグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム] (コード：QYR23MA8209)販売に関する免責事項を必ずご確認ください。
★調査レポート[口腔内崩壊溶解フィルムのグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆